{"id":"butylphthalide-soft-capsules","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal disturbance"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL248594","moleculeType":"Small molecule","molecularWeight":"190.24"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Butylphthalide is a neuroprotective agent that works primarily by enhancing mitochondrial ATP production and reducing free radical-induced cellular damage. It decreases inflammatory cytokine release and apoptosis in ischemic brain tissue, thereby limiting the extent of neuronal death and promoting recovery of neurological function after acute ischemic stroke.","oneSentence":"Butylphthalide protects brain cells by improving mitochondrial function and reducing oxidative stress and inflammation following ischemic stroke.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:16:55.862Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute ischemic stroke"},{"name":"Post-stroke neurological recovery"}]},"trialDetails":[{"nctId":"NCT03804229","phase":"PHASE3","title":"Efficacy and Safety of Butylphthalide Soft Capsule for the Treatment of Vascular Dementia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Capital Medical University","startDate":"2019-10-29","conditions":"Vascular Dementia","enrollment":707},{"nctId":"NCT07369999","phase":"PHASE3","title":"Effects of Butylphthalide Enhanced With Tenecteplase on Neurological Function in Mild Disabling Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Xiangya Hospital of Central South University","startDate":"2026-02-01","conditions":"Mild Disabling Acute Ischemic Stroke","enrollment":1062},{"nctId":"NCT07252544","phase":"PHASE3","title":"Isosorbide Mononitrate and Butylphthalide to Reduce the Risk of Disability in Patients With Acute Lacunar Stroke (IMPACT)","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-12-01","conditions":"Stroke, Lacunar, Stroke, Acute Ischemic, Cerebral Small Vessel Diseases","enrollment":3156},{"nctId":"NCT07230587","phase":"PHASE3","title":"Butylphthalide for Long-term Efficacy in Minor Stroke Study","status":"NOT_YET_RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2025-12-01","conditions":"Ischemic Stroke, Minor Stroke","enrollment":1200},{"nctId":"NCT07193277","phase":"PHASE4","title":"Butylphthalide for Cognitive Impairment in Elderly Patients With Focal Epilepsy","status":"RECRUITING","sponsor":"First Affiliated Hospital of Wenzhou Medical University","startDate":"2025-09-01","conditions":"Focal Epilepsy, Cognitive Impairment","enrollment":220},{"nctId":"NCT06704685","phase":"PHASE3","title":"A Randomized Controlled Trial on the Efficacy and Safety of Butylphthalide in Reducing Myocardial Infarction Size and Improving Outcomes in STEMI Patients After Primary PCI","status":"NOT_YET_RECRUITING","sponsor":"Xiangya Hospital of Central South University","startDate":"2024-12-01","conditions":"ST-segment Elevation Myocardial Infarction (STEMI)","enrollment":40},{"nctId":"NCT06508671","phase":"PHASE4","title":"Effects of DL-3-n-butylphthalide on Chemotherapy-Induced Cognitive Impairment","status":"NOT_YET_RECRUITING","sponsor":"First Hospital of China Medical University","startDate":"2024-07","conditions":"Chemotherapy-Related Cognitive Impairment, DL-3-n-butylphthalide","enrollment":100},{"nctId":"NCT05976152","phase":"PHASE3","title":"Effect of Butyphthalide on Cognitive Level Change After Cerebral Vascular Event-a Randomized Control Trial (Be-CLEVER)","status":"RECRUITING","sponsor":"Fudan University","startDate":"2024-04","conditions":"Stroke, Post-stroke Cognitive Impairment (PSCI)","enrollment":3200},{"nctId":"NCT05068349","phase":"PHASE4","title":"For Patients With Ischemic Stroke, Clinically Study the Effectiveness and Safety of Butylphthalide.","status":"RECRUITING","sponsor":"Qianfoshan Hospital","startDate":"2022-05-07","conditions":"Stroke, Cerebral Infarction, Brain Infarction","enrollment":300},{"nctId":"NCT06331494","phase":"NA","title":"Efficacy of Butylphthalide on Symptomatic Atherosclerotic Stenosis in Middle Cerebral Artery","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital, Sun Yat-Sen University","startDate":"2024-03-15","conditions":"Ischemic Stroke, Acute, Intracranial Atherosclerosis","enrollment":140},{"nctId":"NCT03539445","phase":"PHASE3","title":"Efficacy and Safety of Butylphthalide for Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis or Endovascular Treatment","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2018-07-01","conditions":"Acute Ischemic Stroke","enrollment":1216},{"nctId":"NCT04091412","phase":"PHASE4","title":"Study of Collateral Circulation in Patients With Symptomatic Intracranial Anterior Circulation Occlusion","status":"UNKNOWN","sponsor":"The Second Hospital of Hebei Medical University","startDate":"2019-05-05","conditions":"Collateral Circulation, Large-artery Occlusion, Cerebral Infarction","enrollment":500},{"nctId":"NCT04078204","phase":"NA","title":"A Clinical Study on the Treatment of Cerebral Small Vascular Disease","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2018-04-25","conditions":"Cerebral Small Vessel Diseases","enrollment":300},{"nctId":"NCT03906123","phase":"NA","title":"The Efficacy of DL-NBP in Patients With Mild Subcortical Ischemic Vascular Dementia","status":"UNKNOWN","sponsor":"Tianjin Medical University General Hospital","startDate":"2017-11-18","conditions":"Subcortical Vascular Dementia, Cerebral Small Vessel Diseases","enrollment":64},{"nctId":"NCT02993367","phase":"PHASE2, PHASE3","title":"The Efficacy of Butylphthalide Soft Capsules in Patents With VCIND","status":"UNKNOWN","sponsor":"The Second Hospital of Hebei Medical University","startDate":"2017-01","conditions":"Vascular Cognitive Impairment no Dementia","enrollment":200},{"nctId":"NCT00724724","phase":"PHASE4","title":"The Effectiveness and Safety of Butylphthalide Soft Capsules in Secondary Prevention of Ischemic Stroke Trial","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2008-08","conditions":"Stroke, Transient Ischemic Attack","enrollment":1000}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"DERMATITIS"}],"_approvalHistory":[],"publicationCount":7,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Butylphthalide Soft Capsules, En Bi Pu (NBP)","NBP"],"phase":"marketed","status":"active","brandName":"Butylphthalide Soft Capsules","genericName":"Butylphthalide Soft Capsules","companyName":"Peking Union Medical College Hospital","companyId":"peking-union-medical-college-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Butylphthalide protects brain cells by improving mitochondrial function and reducing oxidative stress and inflammation following ischemic stroke. Used for Acute ischemic stroke, Post-stroke neurological recovery.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}